Therefore, the Th1/Th17 cell ratio along with the IFN-γ/IL-17F cytokine ratio analysis suggests a progression from a Th1 phenotype toward a Th17 phenotype as disease evolves from CIS to RR or PP subtypes. Here, IL17F is linked to in situ carcinoma.